Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Visual Fields | 5 | 2008 | 1062 | 0.630 |
Why?
|
| Dominance, Cerebral | 4 | 2004 | 623 | 0.480 |
Why?
|
| Consciousness | 1 | 2019 | 601 | 0.430 |
Why?
|
| Functional Laterality | 4 | 2008 | 2256 | 0.400 |
Why?
|
| Models, Neurological | 1 | 2019 | 1767 | 0.360 |
Why?
|
| Electric Stimulation Therapy | 2 | 2008 | 627 | 0.320 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 2160 | 0.260 |
Why?
|
| Psychotherapy | 4 | 2020 | 1647 | 0.230 |
Why?
|
| Photic Stimulation | 2 | 1999 | 1985 | 0.200 |
Why?
|
| Affect | 3 | 1999 | 1485 | 0.200 |
Why?
|
| Electromagnetic Fields | 1 | 2002 | 296 | 0.170 |
Why?
|
| Eye Protective Devices | 3 | 2008 | 33 | 0.160 |
Why?
|
| Emotions | 3 | 2019 | 2738 | 0.160 |
Why?
|
| Ear Canal | 1 | 1999 | 147 | 0.150 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2008 | 1472 | 0.150 |
Why?
|
| Electrons | 1 | 2019 | 265 | 0.150 |
Why?
|
| Visual Cortex | 1 | 2004 | 1107 | 0.130 |
Why?
|
| Body Temperature | 1 | 1999 | 782 | 0.130 |
Why?
|
| Cerebral Cortex | 3 | 2004 | 5776 | 0.120 |
Why?
|
| Personality | 1 | 2019 | 554 | 0.120 |
Why?
|
| Photons | 1 | 2019 | 589 | 0.120 |
Why?
|
| Brain | 2 | 2019 | 27103 | 0.120 |
Why?
|
| Life Change Events | 2 | 1999 | 952 | 0.110 |
Why?
|
| Attention | 1 | 2004 | 2395 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2004 | 2884 | 0.110 |
Why?
|
| Microtubules | 1 | 2019 | 1074 | 0.110 |
Why?
|
| Perception | 1 | 2019 | 1197 | 0.100 |
Why?
|
| Electroencephalography | 2 | 1999 | 6224 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 4063 | 0.090 |
Why?
|
| Brain Mapping | 3 | 2019 | 6626 | 0.080 |
Why?
|
| Arousal | 1 | 1995 | 1166 | 0.080 |
Why?
|
| Calcium-Transporting ATPases | 3 | 1997 | 122 | 0.080 |
Why?
|
| Mental Recall | 1 | 1995 | 1214 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 1997 | 163 | 0.080 |
Why?
|
| Depressive Disorder | 2 | 1999 | 3728 | 0.080 |
Why?
|
| Vision, Monocular | 2 | 1999 | 71 | 0.070 |
Why?
|
| Depression | 1 | 2008 | 8122 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 1998 | 241 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8997 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 1997 | 2717 | 0.070 |
Why?
|
| Pain | 1 | 2020 | 5077 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2002 | 4760 | 0.060 |
Why?
|
| Personality Assessment | 2 | 1997 | 650 | 0.060 |
Why?
|
| Fixation, Ocular | 1 | 2004 | 242 | 0.050 |
Why?
|
| Cocaine | 1 | 1988 | 958 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6987 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 1998 | 1039 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 1998 | 1517 | 0.050 |
Why?
|
| Diastole | 3 | 1997 | 782 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2004 | 551 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6231 | 0.040 |
Why?
|
| Personality Inventory | 1 | 2002 | 1019 | 0.040 |
Why?
|
| Male | 13 | 2020 | 360621 | 0.040 |
Why?
|
| Angina Pectoris | 2 | 1980 | 959 | 0.040 |
Why?
|
| Renin | 2 | 1997 | 639 | 0.040 |
Why?
|
| Eyeglasses | 1 | 1999 | 137 | 0.040 |
Why?
|
| Female | 12 | 2020 | 392485 | 0.030 |
Why?
|
| Humans | 17 | 2020 | 761326 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 1998 | 195 | 0.030 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 1995 | 4579 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2004 | 36430 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1998 | 897 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 1997 | 1069 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 1997 | 591 | 0.030 |
Why?
|
| Adult | 9 | 2008 | 221122 | 0.030 |
Why?
|
| Myocardium | 5 | 1998 | 4723 | 0.030 |
Why?
|
| Stress, Psychological | 3 | 1980 | 4477 | 0.030 |
Why?
|
| Hypertension | 3 | 1998 | 8539 | 0.030 |
Why?
|
| Mice | 3 | 2019 | 81474 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1998 | 850 | 0.030 |
Why?
|
| Calcium | 2 | 1996 | 5726 | 0.030 |
Why?
|
| Middle Aged | 9 | 2008 | 220774 | 0.030 |
Why?
|
| Oxygen | 1 | 2004 | 4227 | 0.030 |
Why?
|
| Self Concept | 1 | 1998 | 1043 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 1997 | 1516 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 3 | 1998 | 350 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 80575 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 1996 | 751 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15262 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1988 | 4419 | 0.020 |
Why?
|
| Sodium | 1 | 1996 | 1588 | 0.020 |
Why?
|
| Angiotensin II | 3 | 1998 | 849 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1996 | 829 | 0.020 |
Why?
|
| Prognosis | 2 | 2002 | 29588 | 0.020 |
Why?
|
| Animals | 6 | 2019 | 168388 | 0.020 |
Why?
|
| RNA, Messenger | 4 | 1997 | 12787 | 0.020 |
Why?
|
| Electrocardiography | 3 | 1980 | 6382 | 0.020 |
Why?
|
| Animals, Genetically Modified | 3 | 1998 | 1561 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 1995 | 1037 | 0.020 |
Why?
|
| Memory | 1 | 1998 | 2187 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1997 | 1313 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1995 | 1496 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1997 | 2775 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 2110 | 0.020 |
Why?
|
| Adrenal Glands | 2 | 1964 | 551 | 0.020 |
Why?
|
| Family | 1 | 1995 | 3197 | 0.010 |
Why?
|
| Mental Health | 1 | 1998 | 3248 | 0.010 |
Why?
|
| Adrenocortical Adenoma | 1 | 1964 | 46 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1996 | 7045 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 1964 | 170 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1996 | 4936 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2002 | 64645 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1998 | 8166 | 0.010 |
Why?
|
| Aged | 3 | 2008 | 169179 | 0.010 |
Why?
|
| Rats | 5 | 1998 | 23729 | 0.010 |
Why?
|
| Heart Failure | 2 | 1996 | 11672 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1964 | 346 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1976 | 5919 | 0.010 |
Why?
|
| Exercise Test | 2 | 1980 | 2129 | 0.010 |
Why?
|
| Adolescent | 2 | 1999 | 88305 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1964 | 732 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1998 | 8485 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 1998 | 60 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 1997 | 110 | 0.010 |
Why?
|
| Angiotensin I | 1 | 1997 | 56 | 0.010 |
Why?
|
| Dihydropyridines | 1 | 1997 | 68 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 1998 | 153 | 0.010 |
Why?
|
| Neuropeptide Y | 1 | 1998 | 192 | 0.010 |
Why?
|
| Captopril | 1 | 1997 | 265 | 0.010 |
Why?
|
| Heart Rate | 2 | 1980 | 4197 | 0.010 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 1996 | 89 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1996 | 395 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 1996 | 87 | 0.010 |
Why?
|
| Tape Recording | 1 | 1976 | 77 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 1997 | 404 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 1545 | 0.010 |
Why?
|
| Azetidines | 1 | 1996 | 140 | 0.010 |
Why?
|
| Systole | 1 | 1997 | 937 | 0.010 |
Why?
|
| Behavior | 1 | 1978 | 540 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1998 | 23427 | 0.010 |
Why?
|
| Heart Ventricles | 2 | 1997 | 3816 | 0.010 |
Why?
|
| Heart | 2 | 1998 | 4405 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1980 | 1863 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 950 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1976 | 1626 | 0.010 |
Why?
|
| Occupations | 1 | 1976 | 515 | 0.010 |
Why?
|
| Adenoma | 1 | 1964 | 2159 | 0.010 |
Why?
|
| Organ Size | 1 | 1998 | 2252 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1978 | 15499 | 0.010 |
Why?
|
| Tetrazoles | 1 | 1997 | 910 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1997 | 5034 | 0.010 |
Why?
|
| Collagen | 1 | 1997 | 2638 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1980 | 3094 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1997 | 4167 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1964 | 6332 | 0.000 |
Why?
|
| Risk | 1 | 1978 | 9605 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 9534 | 0.000 |
Why?
|
| Thinness | 1 | 1947 | 490 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1978 | 9319 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 11070 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1997 | 18234 | 0.000 |
Why?
|
| Neoplasms | 1 | 1964 | 22158 | 0.000 |
Why?
|
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_